Attached files

file filename
10-Q/A - GENETHERA, INC. MARCH 31, 2018 10-Q/A, AMENDMENT NO. 1 - GENETHERA INCgenethera_10q-17544.htm
EX-32.1 - CERTIFICATE OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, A - GENETHERA INCexhibit_32-1.htm
EX-31.2 - CERTIFICATE OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBAN - GENETHERA INCexhibit_31-2.htm
EX-31.1 - CERTIFICATE OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBAN - GENETHERA INCexhibit_31-1.htm
 
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Tannya L. Irizarry, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q/A of GeneThera, Inc. for the quarterly period ended March 31, 2018, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Quarterly Report on Form 10-Q/A fairly presents in all material respects the financial condition and results of operations of GeneThera, Inc.
 
By: /s/ Tannya L Irizarry
Name: Tannya L Irizarry
Title: Chief Financial Officer (Interim) (Principal Financial/Accounting Officer)
Date: December 3, 2018